Skip to main content

Table 2 Summary of quality indicators for studies of acetylcysteine for prevention of contrast-induced nephropathy.

From: Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis

First Author

Jadad score

Inclusion/exclusion criteria specified

Randomization process described

Use of any blinding

Placebo-controlled

Reported loss to follow-up

Intention-to treat analysis

Potential important baseline differences

Power calculation

Allaqaband 25

3

yes/no

yes

yes

yes

no

no

no

yes

Baker 26

2

yes/yes

yes

no

yes

no

yes

no

yes

Briguori 27

1

yes/no

yes

no

no

no

unclear

yes

no

Diaz-Sandoval 28

4

yes/yes

yes

yes

no

yes

unclear

yes

no

Durham 29

5

yes/yes

yes

yes

yes

yes

unclear

no

yes

Efrati 30

4

yes/yes

no

yes

yes

yes

unclear

no

no

Fung 31

4

yes/yes

yes

no

no

no

yes

no

yes

Goldenberg 32

5

yes/yes

yes

yes

yes

no

unclear

no

yes

Kay 33

5

yes/yes

yes

yes

yes

yes

yes

no

yes

Kefer 34

4

yes/yes

yes

yes

yes

yes

unclear

yes

no

MacNeill 35

4

yes/yes

yes

no

yes

no

unclear

no

yes

Oldemeyer 36

4

yes/yes

yes

yes

no

yes

unclear

no

no

Shyu 37

3

yes/yes

yes

yes

no

yes

unclear

no

no

Vallero 38

2

yes/yes

yes

no

no

no

unclear

yes

no

  1. Legend: NR = not recorded or available; Jadad score range 0–5.